Latest Health News

Symal Group (ASX: SYL) delivered record FY26 results, surpassing $1 billion in revenue and completing four strategic acquisitions to diversify its infrastructure services platform.

Desane Group Holdings projects FY26 EBIT between $0.9 million and $1.0 million, a steep drop from $5.4 million last year, ahead of audited results due by month-end.

Supply Network Limited reported a 15.4% rise in FY2026 revenue to $403.7 million and a 19% jump in net profit to $47.6 million, underpinning a 44-cent fully franked final dividend. The company is advancing major branch expansions and IT upgrades to support its $50 million revenue growth target for FY2027.

Regis Healthcare reported a robust FY26 with revenue hitting $1.35 billion, underpinned by strong occupancy and strategic acquisitions. The company is investing heavily in growth and digital transformation while navigating sector reforms and climate risks.

Cyclopharm Limited posted a fifth consecutive record half-year revenue of $17.5 million, propelled by a 74% jump in US Technegas® sales and a doubling of revenue-generating US sites. New US clinical guidelines naming Technegas® as the preferred ventilation imaging agent underpin a robust growth outlook despite a wider net loss.

nib Group reported a 6.2% revenue increase to $3.8 billion and a 9.1% rise in underlying operating profit to $260.9 million for FY26, despite a 5.9% net profit dip. The company achieved maiden profitability in Health Services and declared a fully franked 21c dividend including a 5c special, supported by ongoing Travel insurance divestments.

BCAL Diagnostics has updated investors on its $10 million convertible note facility, revealing $7.6 million drawn to date with further funding contingent on upcoming shareholder approval.

South Port New Zealand has delivered a record full-year profit in FY26, driven by a strong 11.5% rise in cargo volumes and significant container throughput growth. The company is positioning for future expansion amid leadership changes and cautious FY27 outlook.

Charter Hall Social Infrastructure REIT (ASX:CQE) posted a robust FY26 result with a 13.1% rise in operating earnings per unit, driven by strategic acquisitions and disciplined capital recycling. The portfolio now boasts a $2.3 billion valuation, near-full occupancy, and extended lease terms, underpinning income resilience amid ongoing sector demand.

Perpetual Limited will book a non-cash A$63.5 million impairment on goodwill tied to Thompson, Siegel & Walmsley’s International Equity strategy after a major client announced plans to redeem US$4.6 billion in Q2 FY27.

Island Pharmaceuticals has commissioned a second manufacturing run of its antiviral Galidesivir, aiming to stockpile up to 800 treatment courses by late 2026 to support rapid response to the fast-spreading Bundibugyo Ebola outbreak and biodefence efforts.

Pro Medicus' US arm, Visage Imaging, has landed a substantial 7-year, A$25 million contract to deploy its Visage 7 cloud-based imaging platform across Valley Health's hospital network in Virginia and West Virginia.